Related Experiment Video
Updated: Jun 19, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Testing for hepatitis B virus in patients with chronic urticaria and angioedema
Insights
Hepatitis B virus (HBV) infection markers were found in 17.6% of chronic urticaria and angioedema (CUA) patients, a significantly higher rate than the general population. This suggests a potential link between HBV and CUA requiring further investigation.
Area of Science:
- Hepatology
- Immunology
- Dermatology
Background:
- Chronic urticaria and angioedema (CUA) is a complex condition with multifactorial etiologies.
- Hepatitis B virus (HBV) infection is a significant global health concern.
- Investigating potential infectious triggers for chronic inflammatory conditions is crucial.
Observation:
- Serologic markers for HBV infection were assessed in 114 patients diagnosed with CUA.
- Serum samples from 85 (75%) of these patients were analyzed for HBV markers.
- The study aimed to determine the prevalence of HBV infection within this patient cohort.
Findings:
- HBV infection markers were detected in 15 (17.6%) of the CUA patients.
- Specifically, 13 patients (15.3%) showed evidence of past HBV infection (anti-HBs), and 2 patients (2.4%) had active infection (HBsAg).
- The prevalence of HBV infection in CUA patients was notably higher than in the general population.
Implications:
- The findings suggest a potential association between HBV infection and the development or exacerbation of CUA.
- The two patients with HBsAg also received a diagnosis of chronic persistent hepatitis, highlighting a direct health consequence.
- Further research is warranted to elucidate the causal relationship, if any, between HBV infection and CUA.
Abstract:
Serologic markers of hepatitis B virus (HBV) infection were sought in serum from 85 (75%) of 114 consecutive patients with chronic urticaria and angioedema (CUA). Markers of HBV infection were detected in 15 (17.6%) patients. Of these 13 (15.3%) were found to have anti-hepatitis B surface antibody (anti-HBs) and 2 (2.4%) had hepatitis B surface antigen (HBsAg). The frequency of current and previous HBV infection is thus several times greater than that reported in the general population. No patient was found to have anti-HBs and HBsAg detectable in the same sample of blood. A diagnosis of chronic persistent hepatitis was established in the two patients with HBsAg in their circulation. The possibility that CUA was causally related to HBV infection in these two cases, as well as those with anti-HBs, was considered and it was suggested that further exploration of the relationship between CUA and HBV infection is warranted.

